RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - March 28, 2008) - Adherex Technologies Inc.(AMEX: ADH)(TSX: AHX), a biopharmaceutical company devoted to solving problems for patients with cancer, announced today its financial results for the fiscal year ended December 31, 2007. All amounts are in U.S. dollars.
